Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2006 1
2007 1
2010 1
2011 2
2012 7
2013 13
2014 9
2015 9
2016 9
2017 4
2018 6
2019 5
2020 2
2021 13
2022 11
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
IMWG consensus on risk stratification in multiple myeloma.
Chng WJ, Dispenzieri A, Chim CS, Fonseca R, Goldschmidt H, Lentzsch S, Munshi N, Palumbo A, Miguel JS, Sonneveld P, Cavo M, Usmani S, Durie BG, Avet-Loiseau H; International Myeloma Working Group. Chng WJ, et al. Leukemia. 2014 Feb;28(2):269-77. doi: 10.1038/leu.2013.247. Epub 2013 Aug 26. Leukemia. 2014. PMID: 23974982 Review.
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
Jelinek T, Bezdekova R, Zihala D, Sevcikova T, Anilkumar Sithara A, Pospisilova L, Sevcikova S, Polackova P, Stork M, Knechtova Z, Venglar O, Kapustova V, Popkova T, Muronova L, Chyra Z, Hrdinka M, Simicek M, Garcés JJ, Puig N, Cedena MT, Jurczyszyn A, Castillo JJ, Penka M, Radocha J, Mateos MV, San-Miguel JF, Paiva B, Pour L, Rihova L, Hajek R. Jelinek T, et al. Among authors: sevcikova s. J Clin Oncol. 2023 Mar 1;41(7):1383-1392. doi: 10.1200/JCO.22.01226. Epub 2022 Oct 31. J Clin Oncol. 2023. PMID: 36315921 Free PMC article.
Immunomodulatory Agents for Multiple Myeloma.
Minařík J, Ševčíková S. Minařík J, et al. Among authors: sevcikova s. Cancers (Basel). 2022 Nov 23;14(23):5759. doi: 10.3390/cancers14235759. Cancers (Basel). 2022. PMID: 36497241 Free PMC article.
Long Non-Coding RNAs in Multiple Myeloma.
Butova R, Vychytilova-Faltejskova P, Souckova A, Sevcikova S, Hajek R. Butova R, et al. Among authors: sevcikova s. Noncoding RNA. 2019 Jan 24;5(1):13. doi: 10.3390/ncrna5010013. Noncoding RNA. 2019. PMID: 30682861 Free PMC article. Review.
IgG4-related disease. Clinical manifestation differential diagnosis and recent International Diagnostic Criteria for IgG4-related disease.
Adam Z, Zeman D, Čermák A, Dastych M, Doubková M, Horváth T, Skorkovská Š, Adamová Z, Řehák Z, Koukalová R, Pour L, Štork M, Krejčí M, Sandecká V, Ševčíková S, Král Z. Adam Z, et al. Among authors: sevcikova s. Vnitr Lek. 2022 Fall;68(E-5):4-19. doi: 10.36290/vnl.2022.070. Vnitr Lek. 2022. PMID: 36283812 Review. English.
High-risk multiple myeloma: different definitions, different outcomes?
Paszekova H, Kryukov F, Kubiczkova L, Hajek R, Sevcikova S. Paszekova H, et al. Among authors: sevcikova s. Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):24-30. doi: 10.1016/j.clml.2013.09.004. Epub 2013 Sep 28. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24225331 Review.
Mechanism of immunomodulatory drugs in multiple myeloma.
Sedlarikova L, Kubiczkova L, Sevcikova S, Hajek R. Sedlarikova L, et al. Among authors: sevcikova s. Leuk Res. 2012 Oct;36(10):1218-24. doi: 10.1016/j.leukres.2012.05.010. Epub 2012 Jun 21. Leuk Res. 2012. PMID: 22727252 Review.
82 results